It is a radio-labeled Nb developed as an in vivo positron emission tomography (PET) imaging diagnostic tool for Human Epidermal growth factor Receptor 2 (HER2)+ breast cancer molecular phenotyping (13). Here, ERBB2 is linked to breast carcinoma.